5H-Spiro[furo[3,4-b]pyridine-7,4'-piperidin]-5-one hydrochloride

Catalog No.: 
ACXOHC510
CAS No.: 
475152-29-5
Molecular Formula: 
C11H13ClN2O2
Molecular Weight: 
240.69
5H-Spiro[furo[3,4-b]pyridine-7,4'-piperidin]-5-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$215.00InquiryInquiry
1g95%$672.00InquiryInquiry
5g95%$2453.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5H-Spiro[furo[3,4-b]pyridine-7,4'-piperidin]-5-one hydrochloride
IUPAC Name5H-spiro[furo[3,4-b]pyridine-7,4'-piperidin]-5-one hydrochloride
Molecular FormulaC11H13ClN2O2
Molecular Weight240.69
SMILESO=C1OC2(CCNCC2)C3=NC=CC=C31.[H]Cl
InChI KeyBMUNXWGZXMSXSF-UHFFFAOYSA-N
SynonymSPIRO[FURO[3,4-B]PYRIDINE-7(5H),4-PIPERIDIN]-5-ONE HCL;5H-spiro[furo[3,4-b]pyridine-7,4'-piperidin]-5-one hydrochloride;Spiro[furo[3,4-b]pyridine-7(5h),4′-piperidin]-5-one, hydrochloride (1:1)
CAS No.475152-29-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXOHC510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOHC510 route product structure diagram
    ACXOHC510475152-29-5
Inquiry

2. ACXOHC510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOHC510 route product structure diagram
    ACXOHC510475152-29-5
Inquiry

3. ACXOHC510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOHC510 route product structure diagram
    ACXOHC510475152-29-5
Inquiry

Comments (0)